Virulence determinants, antimicrobial susceptibility, and molecular profiles of Erysipelothrix rhusiopathiae strains isolated from China

Figures & data

short-legendFigure 1

Table 1 Distribution of MICs for the 50 E. rhusiopathiae strains

	Number of strains with MIC (μg/mL)
Antibiotics	<0.0625	0.0625	0.125	0.25	0.5	1	2	4	8	16	32	64	128	>128	MIC (μg/mL) on the break point of resistance^a	Number of resistant strains (%)
Kanamycin														48	64	48 (100%)
Gentamicin							1				2	21	13	11	4	47 (98%)
Ampicillin	33	12	3												0.5	0 (0%)
Erythromycin	13	3	25	7											1	0 (10%)
Cefataxime	8	8	20	9	3										64	0 (100%)
Cefazolin														48	32	48 (100%)
Norfloxacin								1	10	15	13	8	1		16	37 (77%)
Levofloxacin						2	12	23	6	2	2	1			4	34 (71%)
Sulfadiazine														48	512	48 (100%)
Amikacin														48	64	48 (100%)
Tetracycline					3	3	3	3	7	5	9	10	5		16	29 (60%)
Doxycycline			2	5	5	1	1	3	13	6	12				16	18 (38%)
Lincomycin				2	4	5	1	1		2	20	9	3	1	2	37 (77%)

^aResistant strains include intermediate resistant and resistant strains from CLIS.¹³

Rankin ID.MIC testing.In: Coyle MB (ed.) Manual of antimicrobial susceptibility testing.Washington, DC: American Society for Microbiology, 2005: 53–62.

 Google Scholar